Literature DB >> 27406348

CLINICAL PRACTICE. Polycystic Ovary Syndrome.

Christopher R McCartney1, John C Marshall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27406348      PMCID： PMC5301909          DOI： 10.1056/NEJMcp1514916

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  46 in total

Review 1.  Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

2.  U S. Medical Eligibility Criteria for Contraceptive Use, 2010.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2010-06-18

3.  Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.

Authors:  V L Nelson; R S Legro; J F Strauss; J M McAllister
Journal:  Mol Endocrinol       Date:  1999-06

4.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

Review 5.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

Review 6.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

7.  Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

Authors:  Didier Dewailly; Marla E Lujan; Enrico Carmina; Marcelle I Cedars; Joop Laven; Robert J Norman; Héctor F Escobar-Morreale
Journal:  Hum Reprod Update       Date:  2013-12-16       Impact factor: 15.610

Review 8.  Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.

Authors:  Brian A Swiglo; Mihaela Cosma; David N Flynn; David M Kurtz; Matthew L Labella; Rebecca J Mullan; Patricia J Erwin; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

9.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

10.  Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.

Authors:  Yana Vinogradova; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ       Date:  2015-05-26
View more
  103 in total

1.  Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.

Authors:  Susan Sam; David A Ehrmann
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 2.  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  A L L Rocha; L C Faria; T C M Guimarães; G V Moreira; A L Cândido; C A Couto; F M Reis
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

3.  Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age.

Authors:  Norbert Gleicher; Vitaly A Kushnir; Sarah K Darmon; Qi Wang; Lin Zhang; David F Albertini; David H Barad
Journal:  Endocrine       Date:  2018-01-06       Impact factor: 3.633

Review 4.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

5.  Commentary: Mendelian randomization and women's health.

Authors:  Jenny C Censin; Jonas Bovijn; Michael V Holmes; Cecilia M Lindgren
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

Review 6.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

Review 7.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

8.  Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome.

Authors:  Behnam Heidari; Amir Lerman; Antigoni Z Lalia; Lilach O Lerman; Alice Y Chang
Journal:  Mayo Clin Proc       Date:  2019-12       Impact factor: 7.616

9.  Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.

Authors:  Uche Ezeh; Andy Huang; Melanie Landay; Ricardo Azziz
Journal:  J Womens Health (Larchmt)       Date:  2018-06-07       Impact factor: 2.681

10.  Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS.

Authors:  Edgar D Torres Fernandez; Alexandra M Huffman; Maryam Syed; Damian G Romero; Licy L Yanes Cardozo
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.